Related Experiment Videos
Unusual extraperitoneal lesion of the pelvis: cloacal cyst with transitional cell carcinoma
International Urology and Nephrology
|January 1, 1977
Abstract:
An unusual cystic tumor of retrovesical space was reported. After puzzling speculation on its histogenesis this extremely rare tumor was concluded to be a cloacal cyst with transitional cell carcinoma. Review of the literature revealed no similar case.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial.
ESMO gastrointestinal oncology·2026
The alarmin interleukin-1α causes preterm birth through the NLRP3 inflammasome.
Molecular human reproduction·2020
Association between muscle-specific strength and disability in instrumental activities of daily living in patients with chronic kidney disease.
International urology and nephrology·2026
Validation of BIAS and IBCG criteria for predicting high-grade recurrence in low-grade NMIBC eligible for active surveillance.
International urology and nephrology·2026
Reevaluating predictive factors for treatment success in therapy with OnabotulinumtoxinA for iOAB in a real-world study.
International urology and nephrology·2026
Cross-cultural translation and psychometric validation of the Arabic Intermittent Catheterization Adherence Scale (ICAS): a bicentric study.
International urology and nephrology·2026
Predicting clinically significant prostate cancer in PI-RADS 3 lesions: an internally validated PSA density-based model with decision-curve analysis.
International urology and nephrology·2026
Role of neoadjuvant chemotherapy in micropapillary urothelial carcinoma: a multi-institutional analysis from the Korean Bladder Cancer Research Group.
International urology and nephrology·2026
Histopathologic Features of an Attenuated Onychomatricoma: A Novel Variant.
Journal of cutaneous pathology·2026
Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II-III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study.
Annals of surgical oncology·2026